[PDF][PDF] LINE1 derepression in aged wild-type and SIRT6-deficient mice drives inflammation

M Simon, M Van Meter, J Ablaeva, Z Ke, RS Gonzalez… - Cell metabolism, 2019 - cell.com
M Simon, M Van Meter, J Ablaeva, Z Ke, RS Gonzalez, T Taguchi, M De Cecco, KI Leonova
Cell metabolism, 2019cell.com
Mice deficient for SIRT6 exhibit a severely shortened lifespan, growth retardation, and highly
elevated LINE1 (L1) activity. Here we report that SIRT6-deficient cells and tissues
accumulate abundant cytoplasmic L1 cDNA, which triggers strong type I interferon response
via activation of cGAS. Remarkably, nucleoside reverse-transcriptase inhibitors (NRTIs),
which inhibit L1 retrotransposition, significantly improved health and lifespan of SIRT6
knockout mice and completely rescued type I interferon response. In tissue culture, inhibition …
Summary
Mice deficient for SIRT6 exhibit a severely shortened lifespan, growth retardation, and highly elevated LINE1 (L1) activity. Here we report that SIRT6-deficient cells and tissues accumulate abundant cytoplasmic L1 cDNA, which triggers strong type I interferon response via activation of cGAS. Remarkably, nucleoside reverse-transcriptase inhibitors (NRTIs), which inhibit L1 retrotransposition, significantly improved health and lifespan of SIRT6 knockout mice and completely rescued type I interferon response. In tissue culture, inhibition of L1 with siRNA or NRTIs abrogated type I interferon response, in addition to a significant reduction of DNA damage markers. These results indicate that L1 activation contributes to the pathologies of SIRT6 knockout mice. Similarly, L1 transcription, cytoplasmic cDNA copy number, and type I interferons were elevated in the wild-type aged mice. As sterile inflammation is a hallmark of aging, we propose that modulating L1 activity may be an important strategy for attenuating age-related pathologies.
cell.com